期刊文献+

胃癌常用化疗药物敏感性标志物研究进展

Progress of chemotherapy drug sensitivity markers for gastric cancer
原文传递
导出
摘要 氟尿嘧啶类、铂类和紫杉类药物是目前胃癌化疗中的3类常用药物。这3类药物作用机制中关键分子生物学标志物表达情况与化疗药物敏感性之间的关系成为目前的研究热点之一,并且是实现胃癌个体化治疗的前提。 Fluorouracil, platinum and taxane' are commonly used in the current chemotherapy of gastric cancer. The relationship between the key molecular biomarkers of mechanism of drug action and drug sensitivity has become a researchful hotspot, which is the prerequisite to achieve individualized treatment of gastric cancer.
出处 《国际肿瘤学杂志》 CAS 2013年第1期61-64,共4页 Journal of International Oncology
关键词 胃肿瘤 药物疗法 生物学标记 肿瘤治疗方案 Stomach neoplasms Drug therapy Biological markers Antineoplastic protocols
  • 相关文献

二级参考文献48

  • 1Japanese Gastric Cancer Association.Japanese Classification of Gastric Carcinoma – 2nd English Edition – Response assessment of chemotherapy and radiotherapy for gastric carcinoma: clinical criteria[J]. Gastric Cancer . 2001 (1)
  • 2Beck A,,Etienne MC,Chéradame S,Fischel JL,Formento P,Renée N,Milano G.A role for dihydropyrimidine dehydro- genase and thymidylate synthase in tumour sensitivity to ?uorouracil. European Journal of Cancer . 1994
  • 3Etienne MC,Chéradame S,Fischel JL,Formento P,Dasson- ville O,Renée N,Schneider M,Thyss A,Demard F,Milano G.Response to?uorouracil therapy in cancer patients:the role of tumoral dihydropyrimidine dehydrogenase activity. Journal of Clinical Oncology . 1995
  • 4Ishikawa Y,Kubota T,Otani Y,Watanabe M,Teramoto T,Kumai K,Kitajima M,Takechi T,Okabe H,Fukushima M.Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-?uoro- uracil on human tumor xenografts in nude mice. Clinical Cancer Research . 1999
  • 5Ususyo N,Yoshida M,Akimoto S,Yano K,Fujiwara R,Yautida S,Hagiike M,Deishi K,Aida F,Okada S,Maeda H.Prediction of effects and side effects of?uoropyrimidine ad- ministered for gastric cancers and criteria of drug selection. Jpn J Cancer Clin . 2004
  • 6Kurebayashi J,Yamamoto Y,Udagawa K,Okubo S,Fuku- shima M,Sonoo H.Establishment of enzyme-linked immu- nosorbent assays for thymidylate synthase and dihydropy- riminide dehydrogenase in cancer tissues. Oncology Reports . 2004
  • 7Ichikawa W,Takahashi T,Sudo K,Mituyoshi S,Yamashita T,Sirota Y,Nihei Y,Hirayama K.Predictive values of thymi- dine synthase and dehydropyrimidine dehydrogenase gene expression in gastric cancer patients treated with S-1 based chemotherapy. Jpn J Cancer Clin . 2003
  • 8Meropol NJ,Gold PJ,Diasio RB,Andria M,Dhami M,Godfrey T,Kovatich AJ,Lund KA,Mitchell E,Schwarting R.Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients withmetastatic colorectal cancer. Journal of Clinical Oncology . 2006
  • 9Fukui Y,,Oka T,Nagayama S,Danenberg PV,Danenberg KD,Fukushima M.Thymidylate synthase,dihydropyrimi- dine dehydrogenase,orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis. International Journal of Molecular Medicine . 2008
  • 10Koga M,Anegawa E,Yoh J,Tsuyama H,Sakaino H,Iwa- moto O,Koga C,Kusukawa J.Clinical relevance of thymi- dylate synthase(TS)activity for S-1-based chemotherapy in squamous cell carcinoma of the oral cavity. Br J Oral Maxil- lofac Surg . 2010

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部